The pharmaceutical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a promising development. Unlike injections, this method offers a less invasive way to administer GLP-1 therapies. These transdermal systems steadily release the drug through the epidermis offering a even dose of the therapeutic agent, which… Read More